Navigation Links
eDiets.com(R) Announces Q1 2008 Results
Date:5/13/2008

ents. eDiets.com's unique infrastructure offers businesses, as well as individuals, an end-to-end solution strategically tailored to meet its customers' specific goals of achieving a healthy lifestyle. For more information, please call 310-954-1105 or visit http://www.eDiets.com.

* Use of Non-GAAP Financial Measures

In its earnings releases, conference calls, slide presentations or webcasts, the Company may use or discuss adjusted EBITDA, which is a non-GAAP financial measure as defined by SEC Regulation G. Management regularly reviews adjusted EBITDA as an analytical indicator of the Company's financial performance and believes that it is useful to investors in evaluating operating performance. In addition, the Company uses adjusted EBITDA as a measure of performance for its business segments and for incentive compensation purposes. The Company does not intend for adjusted EBITDA to be considered in isolation or as a substitute for any GAAP measure. Adjusted EBITDA, as presented, may not be comparable to similarly titled measures of other companies.

Three Months Ended

March 31,

2008 2007

Net (loss) income $(5,125) $(1,257)

Interest, net 346 (42)

Amortization of secured notes 260 -

Income tax (benefit) provision (33) 59

Depreciation 299 232

Amortization of Intangibles 292 302

Stock-based compensation 468 172

Loss on disposition of fixed assets 3 -
'/>"/>

SOURCE eDiets.com, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
2. eDiets.com(R) Announces Q4 and Year End 2007 Results
3. eDiets.com(R) to Report First Quarter 2008 Results on Tuesday, May 13, 2008
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ield University are in the hope of using stem cell... by creating embryonic stem cells // from the inne...he researchers have tried to regenerate the damage... make them divide into required cell, which has le...
...ry popular drink in Europe and more so in Germany....ave manufactured a healthy beer called karla //, w...nd also prevent cancer. The beer is made form her...oya extract, folic acid and vitamins. It is also w...
...ealed that a IQ level is directly linked to growth...s directly linked to the IQ level of the child, ac...rs. This study also reveals that the children who ... comparison to shorter children. If growth hormone...
... AIDS Day, the Vatican has condemned a culture of ...rted that the best way to prevent the spread // o...icted to marriage and intensifying the strength of...ternational day of action on HIV and AIDS, is comm...
Other Medicine News:
(Date:9/4/2008)...ime PCR testing for the diagnostic ...4 /- The U.S. Food & Drug,Administrat...) HBV Test,the first assay for quantitating Hepat...s Roche,s real-time PCR technology to quantify the...ood. Doctors may use viral load,testing results to...
(Date:9/4/2008)...Newswire/ -- Axentis Pharma AG has,initiated a cli...erability,of a new therapeutic formulation for the... fibrosis patients. The new formulation allows an,...ctly to the site of,infection. The forthcoming tri...doses of the new drug. Initial results are expecte...
(Date:9/3/2008)...RNewswire-FirstCall/ --,Pharmaceutical company Pha...at it has enrolled the first subject into its seco...hitol in cystic fibrosis sufferers., The Phase 3 ...rth,America, Argentina and Germany, and is the fin...o market Bronchitol for cystic fibrosis in the,Uni...
(Date:9/3/2008)...r Disease Awareness Month, CHARLOTTESVILLE, Va., ...LLC, a clinical-stage drug-development company com...medical needs, announced today that it has begun,t...f its lead drug,candidate trans sodium crocetinate...linicaltrials.gov Website, is investigating TSC as...
Breaking Medicine Technology:FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved 779 1Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved 779 2Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved 779 3Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 1Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 2Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 3Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 4Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 5Video 3A Quest Diagnostics Health Trends 28TM 29 Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 777 6AtriCure Reports Third Quarter 2007 Financial Results 5711 1AtriCure Reports Third Quarter 2007 Financial Results 5711 2AtriCure Reports Third Quarter 2007 Financial Results 5711 3AtriCure Reports Third Quarter 2007 Financial Results 5711 4AtriCure Reports Third Quarter 2007 Financial Results 5711 5AtriCure Reports Third Quarter 2007 Financial Results 5711 6AtriCure Reports Third Quarter 2007 Financial Results 5711 7AtriCure Reports Third Quarter 2007 Financial Results 5711 8AtriCure Reports Third Quarter 2007 Financial Results 5711 9Synchrotron radiation illuminates how babies protective bubble bursts 1711 1Synchrotron radiation illuminates how babies protective bubble bursts 1711 2
...IEGO--(BUSINESS WIRE)--Mar 26, 2007 - Inovio Biome...velopment of DNA vaccines and,a novel solid tumor ... of Virology has published a scientific paper prep...ding results from a,non-human primate study of an ...using Inovio Biomedical,s electroporation technolo...
...ple Mechanisms for Panzem NCD, MKC-1, and ENMD-119...e, ROCKVILLE, Md., March 26, 2007 /PRNewswire-Firs...eutical company developing,therapeutics for the tr... announced the presentation of comparative mechani...e compounds Panzem(R), MKC-1,and ENMD-1198. These ...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 2Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 3Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 4EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 2EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 3EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 4
CVC 223 is an assayed quality control material used for confirming the calibration and linearity of CO-Oximeter instrumentation.
...ol material used for monitoring the performance of...tation. It is for specific use on Bayer analyzers ...ions (280, 288, and 270) and the AVOX Systems CO-O... on the IRMA TRUpoint®. CC 527 is available i...
QC 623 is an assayed quality control material for blood gas and electrolyte instrumentation. It is available in four (4) levels for monitoring analyzer performance at varying points within the clinic
Equinox is a truly unique approach to cosmetic enhancement contact lenses and is worn as a conventional wear lens.
Medicine Products: